FDA Drugs (New Approvals & NDA)Original article
Good Clinical Practices Are Not Optional: The FDA’s Commitment to Human Subject Protections and Gold Standard Science in an Era of Global Clinical Research
RegulatoryNeutral
AI Analysis
Summary
The FDA reaffirms that Good Clinical Practices (GCP) are fundamental to regulatory decisions and human subject protections, not merely bureaucratic procedures, in the context of global clinical research.
Importance:1/10
Sentiment:
0.00
FDAGCPregulatoryhuman subject protectionclinical research standards
Read the original article
Published by FDA Drugs (New Approvals & NDA) on September 3, 2026 3:40 PM